Diagnosis and/or typing marker for PCOS (polycystic ovarian syndrome) and application of preparation reagent

A technology for use and detection reagents, which is applied in the field of diagnosis and/or typing markers of polycystic ovary syndrome and preparation of reagents, can solve problems such as high cost and complicated diagnosis of polycystic ovary syndrome, and reduce the detection rate. Cost, Effects of Solving Diagnostic Complexity
CN106442764AActive Publication Date: 2017-02-22王义明
5 Cites 7 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
王义明
Publication Date
2017-02-22

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a diagnosis and / or typing marker for the PCOS (polycystic ovarian syndrome) and an application of the preparation reagent and particularly relates to an application of cyclic guanosine monophosphate, dehydroepiandrosterone sulfate, palm sphingomyelin combined HDL-C (high-density lipoprotein cholesterol) and the left follicle number as the diagnosis and / or typing marker for the PCOS. Compared with existing PCOS diagnosis clinical indexes, the marker can realize the effect of distinguishing a PCOS subgroup I and a PCOS subgroup II through combined diagnosis of cyclic guanosine monophosphate, dehydroepiandrosterone sulfate and palm sphingomyelin. In combination of combined diagnosis of HDL-C (high-density lipoprotein cholesterol) and the left follicle number, the very high diagnosis accuracy is realized for a normal group, the PCOS subgroup I and the PCOS subgroup II, and accurate and effective index systems are provided for clinical disease diagnosis.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of disease diagnosis based on biomarkers, and in particular relates to diagnostic and / or typing markers and reagents for polycystic ovary syndrome. Background technique

[0002] Polycystic ovary syndrome (PCOS) was first proposed by Stein and Leventhal in 1935. It is an endocrine syndrome characterized by reproductive disorders and metabolic disorders. Persistent anovulation, hyperandrogenism, and insulin resistance are its important features. It is the most common endocrine disorder in women of childbearing age. Its biochemical changes, pathogenesis, and clinical manifestations are highly heterogeneous, and its etiology has not yet been elucidated. The treatment methods are still at the level of symptomatic treatment and ovulation induction, and there is no specific treatment method yet.

[0003] Western medicine clinical diagnostic criteria for polycystic ovary syndrome (Rotterdam diagnostic criteria): â‘´ ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More